Diagnosing, treating 'superbugs' is goal of clinical team

December 15, 2016 by Jen Singer

Dr. Michael Satlin's patients aren't just battling cancer. Many are also fighting drug-resistant bacteria – "superbugs" that threaten their fragile immune systems, and their lives.

"They can die within hours or days of infection if they're not properly treated, because they have no immune system," said Satlin, assistant professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine. His patients typically spend weeks in the hospital to receive intensive chemotherapy or bone marrow transplants to treat acute forms of leukemia or other blood cancers. The goal is remission, but both the cancer and treatments for the disease can reduce the body's levels of healthy , which fight infection.

"It can take days for the lab to figure out what they're infected with and which antibiotic they need," he said, "but we can't take the chance of not starting an antibiotic right away."

What's more, these patients are highly susceptible to hospital-acquired antibiotic-resistant infections, including carbapenem-resistant Enterobacteriaceae (CRE), in part because antibiotics and chemotherapy can disrupt the composition of gut bacteria. These can also spread to other seriously ill people who have disrupted microbiomes, collections of microbes living in the body.

Now, with his upstate colleague Ilana Brito, Satlin is studying how genes that lead to resistance to antibiotics proliferate in the gut. The two recently received a $500,000 grant from the Centers for Disease Control and Prevention to learn more about antibiotic resistance in leukemia patients and transplant recipients with neutropenia, or low levels of infection-fighting white blood cells.

"These are nasty bacteria that should keep us awake at night," said Brito, assistant professor of biomedical engineering at Cornell's Meinig School of Biomedical Engineering.

"We are developing new technologies to monitor and track genes in ways not previously done," she says. "If we can understand how these genes spread, we could interfere early to halt the spread of drug resistance."

The collaboration between Brito in Ithaca and Satlin in New York City could ultimately affect the 20,000 adults diagnosed with acute myeloid leukemia each year, as well as other cancer patients treated with .

"Our expertise nicely dovetails with each other's," said Brito, who has implemented metagenomics – the study of entire microbial communities – to learn how genes can transfer between organisms.

"I've always wanted to work with someone who would investigate the microbiome and resistance from a metagenomic standpoint," said Satlin, whose research emphasizes multidrug-resistant infections in and blood cancer patients. He said Brito has the expertise to apply new and exciting technologies that will allow them to characterize the gut microbiome and the spread of antibiotic-resistant genes in ways not possible until recently.

As work begins on the project, stool samples from Satlin's patients are being frozen and shipped to Brito's lab for evaluation. "If we know the genes a person is carrying in their microbiome, then perhaps those could be tested in real time," Brito said. The hope is to be able to identify the specific antibiotic that would work for each patient with an immune system compromised by cancer treatments. Satlin added, "The strategy is to personalize antibiotics instead of all patients getting the same one."

Meanwhile, the research partners continue to learn from each another. "We come at it from different perspectives," Satlin said. "She has a skill set I don't have." He cites Brito's experience characterizing microbiomes in populations in Fiji – a first-of-its-kind study designed to compare mobile genes among diverse populations around the world, which could provide insights for determining how genes lead to in .

Satlin's clinical experience with neutropenic leukemia prompted Brito to suggest that they work together. "He knows the infections they normally present with and the antibiotic-resistant those pathogens carry," she said.

"We have started to teach each other about what we do," Satlin said.

Brito added, "It's a most wonderful collaboration."

Explore further: Understanding drug-resistant superbugs

Related Stories

Understanding drug-resistant superbugs

July 18, 2016
News reports reveal drug-resistant super bacteria identified as carbapenem-resistant Enterobacteriaceae (CRE) have been found in the waters of Rio de Janeiro where the 2016 Olympics sailing events will be held.

Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent Clostridium difficile infection

May 18, 2016
Clostridium difficile is a very common type of infection to which all of us are potentially exposed. However, some people find it harder to heal and traditional antibiotic treatments do not seem to have good results for everybody. ...

New mathematical model challenges aggressive antibiotic treatments

April 19, 2016
Antibiotic resistance is one of the most challenging problems in modern medicine. A new study by Erida Gjini and Patricia H. Brito from the Instituto Gulbenkian de Ciência (IGC; Portugal), provides a new mathematical model ...

Special collection presents the state of science for evaluating antibiotic resistance in agroecosystems

March 3, 2016
The World Health Organization has identified antibiotic resistance as a serious threat to human health across the world. The Journal of Environmental Quality (JEQ) recently published a special section titled "Antibiotics ...

Recommended for you

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

Norovirus evades immune system by hiding out in rare gut cells

October 11, 2017
Noroviruses are the leading cause of non-bacterial gastroenteritis in the world and are estimated to cause 267 million infections and 20,000 deaths each year. This virus causes severe diarrhea, nausea, and stomach pain.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.